A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
Part of paid clinical trials in Santa Monica, California.
- Sponsor
- Athletic Greens International
- Study ID
- NCT07437911
- Status
- Recruiting
Conditions
- GLP-1
- Gastrointestinal Microbiome
- Nutrition Intake
- Nutrition Status
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 59 Years
- Healthy Volunteers
- Not accepted
Interventions
- AG1 - Nutritional Supplement — DIETARY_SUPPLEMENTAG1 - Nutritional Supplement
- Placebo — DIETARY_SUPPLEMENTMaltodextrin Placebo
Study Details
This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Feb 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Dietary Supplement: AG1 - Nutritional SupplementAG1 - Nutritional Supplement
- Placebo Comparator: Dietary Supplement: Placebo
Primary Outcome Measure
Nutrient Gaps [ Time Frame: 90 days ]
Central Contacts
- Ellen O'Gorman(805) 292-0714
- Jodi Nicolli
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Citruslabs | Santa Monica | California | 90404-3727 | Director of Customer Success |
Find similar trials in Santa Monica, CA
By research site
Related Studies
- A Study to Explore the Role of Gut Flora in COVID-19 InfectionRecruiting · ProgenaBiome · Ventura, California
- Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.PHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Falls Church, Virginia
- COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCERPHASE1/PHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- MAINTAIN (Mucosal AblatIoN Therapy After INcretins)Recruiting · Dr. Christopher McGowan · Cary, North Carolina